ELAB logo

PMGC HOLDINGS INC

ELABNASDAQ
🏆 #5196 by market capUS Equity
$2.60▼ $0.03 (−1.14%)
Market closed · at close
🔔
Track ELAB
Get earnings, price moves & breaking news on Telegram
Track
24h▼ 1.1%
7d▼ 13.0%
14d▼ 13.0%
30d▼ 29.7%
ytd▼ 99.3%
1y▼ 99.8%
🏦Market Cap
$2M
Small Cap
📈Revenue Growth (YoY)
-76.1%
Declining
📊Gross Margin
10.3%
Thin
💵FCF Margin
-348.4%
Thin
⚖️P/S Ratio
0.8x
Cheap
Otter Score
—
Insufficient data

Trading Snapshot

Day Range
$2.60 – $2.60
52-Week Range
$2.52 – $1,537.44
Volume (shares)
130
Avg Volume (shares)
—
Shares Outstanding
809,579
Next Earnings
—

Fundamentals Snapshot

Annual Revenue
$590,084
Last Q Revenue
$1M
P/E Ratio
-0.0
P/S Ratio
0.8x
EPS (TTM)
$-27.65
Dividend Yield
0.00%
Dilution (1yr)
+3291.7%
ELAB logo

PMGC HOLDINGS INC

ELAB
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$590K▼ −76.1% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
12.7%▼ −82.6% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$7M▲ +295.2% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$6M▲ +16.3% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
2K▲ +3291.7% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$3M▼ −$1M YoY
StockOtter · stockotter.space

About PMGC HOLDINGS INC

PMGC Holdings Inc. functions as a biopharmaceutical firm, primarily dedicated to sourcing and advancing innovative aesthetic and therapeutic solutions. Its flagship product, EL-22, is a pioneering engineered probiotic designed to tackle the critical challenge of maintaining muscle mass during weight reduction regimens, especially those utilizing GLP-1 receptor agonists. Beyond its core operations, the company also engages in medical scientific research and development and manages various investment firms. Formerly known as Elevai Labs, Inc., the organization adopted its current name, PMGC Holdings Inc., in December 2024. Established in 2020, PMGC Holdings Inc. maintains its headquarters in Newport Beach, California.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
💧Dilution★★★★★
Overall Score
Insufficient data
—/100
Analyst data unavailable.

Latest News & Updates

News unavailable.